Product Overview Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that severely impacts cognition and behavior in the elderly. A hallmark pathological feature of AD is the formation of neurofibrillary tangles caused by the excessive phosphorylation of tau proteins.
The Human phosphorylated Tau231 (p-Tau231) detection kit provides a reliable, objective quantitative measure, empowering clinicians to better understand and manage disease progression in affected patients.
Key Features:
- Digital Immunochip Method: A state-of-the-art technology that enhances the detection limits of biomarkers at ultra-low concentrations in the blood.
- p-Tau231 Biomarker: Internationally recognized as a core fluid biomarker (in plasma or CSF) for the diagnosis and staging of Alzheimer’s.
- High Clinical Utility: Specifically designed for the auxiliary diagnosis of AD in elderly populations with dementia.
Technical Specifications:
- Product Name: Human phosphorylated Tau231 protein detection kit.
- Methodology: Digital Immunochip Method.
- Sample Type: Human Plasma.
- Packaging: 48 tests/box or 96 tests/box.
Why Choose Our Solution? Utilizing blood-based p-Tau231 biomarkers significantly reduces patient burden compared to expensive neuroimaging or invasive cerebrospinal fluid tests. It delivers precise quantitative data, enabling clinicians to optimize treatment pathways and support better clinical decision-making.
